Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 81 results for "dr lal pathlabs"

Cash +ve
Outlookbusiness.com

'Healthcare industry to reach $100 bn by 2017'

Dr. Om Manchanda, CEO, Dr. Lal PathLabs Dr Om P. Manchanda (Manchanda), who is the CEO of Dr Lal PathLabs (LPL), holds a bachelor's degree in veterinary science and animal husbandry from the Haryana Agricultural University, Hisar and a ... Afternoon Despatch & Courier, 3 days ago
Cash +ve Outlookbusiness.com, 3 weeks ago
Path to Universal Healthcare goes via Laboratory Medicine Pocket News Alert.com, 4 weeks ago

18 images for dr lal pathlabs

Outlookbusiness.com, 3 weeks ago
Business Standard India, 3 months ago
India Infoline, 6 months ago
Financial Express, 5 months ago
VC Circle, 2 months ago
Financial Express, 6 months ago
Livemint.com, 5 months ago
Moneycontrol.com, 5 months ago
Livemint.com, 7 months ago
Moneycontrol.com, 6 months ago

Dr. Lal PathLabs' nominee director Naveen Wadhera resigns

Dr. Lal PathLabs Ltd has informed BSE that the Company has, on November 30, 2016 received, an intimation dated November 29, 2016 from Mr. Naveen Wadhera, Nominee Director, tendering his resignation from the Company with immediate effect.
 Money Control1 week ago Dr. Lal PathLabs Ltd announces resignation of Naveen Wadhera as Director  Equity Bulls1 week ago Dr. Lal PathLabs Ltd grants 10000 Stock Options  Equity Bulls1 month ago Allotment of Shares to Employees under ESOP 2010 Plan of the Company (SCRIPCODE: 539524)  HT Syndication2 months ago

Dr Lal Pathlabs announces resignation of nominee director

This page uses frames, but your browser doesn't
 Capital Market1 week ago

Dr Lal PathLabs provides update on proposed acquisition of Delta Ria & Pathology

This page uses frames, but your browser doesn't
 Capital Market2 weeks ago Dr Lal Path up 6%, to complete Delta Ria acquisition by Mar 2017  Money Control2 weeks ago

Dr. Lal PathLabs hits record high

Dr. Lal PathLabs surged 4.76% to Rs 1,230.50 at 15:15 IST on BSE after the company said it is in the process of completing the due diligence and legal documentation for the acquisition of Delta Ria & Pathology.
 Business Standard2 weeks ago Dr Lal PathLabs sees margins declining 200-300 bps in 2-3 yrs  Money Control1 month ago

Dr Lal Pathlabs consolidated net profit rises 748.30% in the September 2016 quarter

Capital Market November 3, 2016 Last Updated at 15:57 IST
 Business Standard1 month ago Dr Lal Pathlabs standalone net profit rises 1018.04% in the September 2016 quarter  Business Standard1 month ago

Dr Lal PathLabs Q2 profit rises 8-fold, margin expands to 30.4%

Diagnostic chain Dr Lal PathLabs has reported more than 8-fold increase in consolidated profit at Rs 52.5 crore for July-September quarter compared with Rs 6.2 crore in same period last year. It was partly driven by low base in year-ago period. The company ...
 Money Control1 month ago BRIEF-DR Lal Pathlabs Sept-qtr profit surges  Reuters India1 month ago DR Lal Pathlabs Sept-qtr profit surges  Reuters UK1 month ago BRIEF-Fortis Malar Hospitals Sept-qtr profit falls  Reuters India1 month ago

Buy Dr. Lal Pathlabs with a target of Rs 1230: Edelweiss Financial Services

Edelweiss Financial Services has Buy call on Dr. Lal Pathlabs Ltd. with a target price of Rs 1230 . The current market price of Dr. Lal Pathlabs Ltd. is 1172.05 . The brokerage gave a year for Dr. Lal Pathlabs Ltd. price to reach defined target. The ...
 Economic Times1 month ago Buy Dr. Lal Pathlabs, target Rs 1180 : Edelweiss Financial Services  Economic Times1 month ago

Dr. Lal PathLabs allots equity shares

This page uses frames, but your browser doesn't
 Capital Market2 months ago
Livemint.com

Laurus Labs IPO gets 29% subscription on Day One

Share Tweet Share Share Share The initial public offering (IPO) of Hyderabad-based Indian pharmaceuticals company Laurus Labs Limited received 29 per cent subscription on the first day of the issue on Tuesday. ...
 EHealth Magazine2 days ago Laurus Labs gets Sebi's go ahead for IPO  Livemint.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less